| For: | Dong N, Zhou PP, Li D, Zhu HS, Liu LH, Ma HX, Shi Q, Ju XL. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways. World J Stem Cells 2022; 14(7): 556-576 [PMID: 36157523 DOI: 10.4252/wjsc.v14.i7.556] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v14/i7/556.htm |
| Number | Citing Articles |
| 1 |
Mirjana Jerkic, Katalin Szaszi, John G. Laffey, Ori Rotstein, Haibo Zhang. Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043376
|
| 2 |
Jiaxin Zhang, Weiwei Du, Zongli Zhang, Tao Li, Xingchao Li, Shibing Xi. Research progress of microvascular development in bronchopulmonary dysplasia. Pediatric Investigation 2024; 8(4) doi: 10.1002/ped4.12441
|
| 3 |
Jing Xiong, Qing Ai, Lei Bao, Yuanshan Gan, Xiaoyu Dai, Mei Han, Yuan Shi. Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1111829
|
| 4 |
Xiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, Li Xie, Chun-Ran Xue, Yi-Shu Wang, Xu-Zhong Pei, Meng-Ze Zhang, Ying Zhang, Wen-Bin Wan, Yan Lin, Ye Deng, Xi-Ying Wang, Yi Chen, He Zhu, Lin-Feng Li, Hui-Ming Xu, Jie Ding, Yi-Fan Wu, Ze Wang, Ya-Ying Song, Kan Wang, Hui-Ying Qiu, Yan Zhou, Yu-Yan Jin, Li-Ping Ni, Jia-Li Yan, Quan Guo, Jia-Hui Xue, Yu-Fang Mei, Bi-Yun Qian, Hao-Jun Yu, Yang-Tai Guan. Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trial. Cell Death & Differentiation 2026; doi: 10.1038/s41418-026-01720-x
|
| 5 |
Xuejing Xu, Linghong Liu, Na Dong, Tianqing Xin, Qing Shi, Dong Li, Xiuli Ju. Intratracheal administration of mesenchymal stem cells ameliorates hyperoxia-induced bronchopulmonary dysplasia by inhibiting NLRP3 inflammasome activation: the critical role of Aldh1a2. Stem Cell Research & Therapy 2025; 17(1) doi: 10.1186/s13287-025-04851-z
|
| 6 |
April W. Tan, Xiaoying Tong, Silvia Alvarez-Cubela, Pingping Chen, Aline Guimarães Santana, Alejo A. Morales, Runxia Tian, Rae Infante, Vanessa Nunes de Paiva, Shathiyah Kulandavelu, Merline Benny, Juan Dominguez-Bendala, Shu Wu, Karen C. Young, Claudia O. Rodrigues, Augusto F. Schmidt. c-Myc Drives inflammation of the maternal-fetal interface, and neonatal lung remodeling induced by intra-amniotic inflammation. Frontiers in Cell and Developmental Biology 2024; 11 doi: 10.3389/fcell.2023.1245747
|
| 7 |
Fangjun Huang, Yang He, Meng Zhang, Keren Luo, Jiawen Li, Jiali Li, Xinyu Zhang, Xiaoyan Dong, Jun Tang. Progress in Research on Stem Cells in Neonatal Refractory Diseases. Journal of Personalized Medicine 2023; 13(8) doi: 10.3390/jpm13081281
|
| 8 |
Dongmei Zou, Jinwen Liao, Min Xiao, Liang Liu, Mingguo Xu. Melatonin alleviates hyperoxia‐induced lung injury through elevating MSC exosomal miR‐18a‐5p expression to repress PUM2 signaling. The FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400374R
|
| 9 |
Atul Malhotra, Bernard Thebaud, Madison C. B. Paton, Bobbi Fleiss, Paris Papagianis, Elizabeth Baker, Laura Bennet, Tamara Yawno, Ngaire Elwood, Belinda Campbell, Kirat Chand, Lindsay Zhou, Tayla Penny, Timothy Nguyen, Salvatore Pepe, Alistair J. Gunn, Courtney A. McDonald. Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022). Pediatric Research 2023; 94(5) doi: 10.1038/s41390-023-02707-x
|
| 10 |
Meagan Goates, Amrit Shrestha, Shyam Thapa, Matthew Bettini, Roberto Barrios, Binoy Shivanna. Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. The American Journal of Pathology 2024; 194(11) doi: 10.1016/j.ajpath.2024.07.011
|
| 11 |
Ang Li, Xiaomin Wang, Jiaqi Wu, Guojie Zhao, Na Li, Zhao Wang, Yaqin Li, Yanfu Wang. Mesenchymal stem cells and derived extracellular vesicles in major respiratory diseases: from multifaceted molecular mechanisms to clinical perspectives. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1839015
|
| 12 |
Shohreh Fadaghi, Merat Mahmoodi, Ali Derakhshani, Farnaz Sedghy, Mahdi Ranjkesh, Ahmadreza Behzadi. Enhancement the antioxidative and immunomodulatory functions of mesenchymal stem cells by tetrandrine. Heliyon 2024; 10(16) doi: 10.1016/j.heliyon.2024.e35667
|
| 13 |
Gergely Balázs, András Balajthy, István Seri, Thomas Hegyi, Tibor Ertl, Tamás Szabó, Tamás Röszer, Ágnes Papp, József Balla, Tamás Gáll, György Balla. Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies. Antioxidants 2023; 12(6) doi: 10.3390/antiox12061149
|
| 14 |
Desheng Chen, Zeping Chen, Jiabin Yuan, Guanzi Chen, Yutao Chen, Kaiming He, Yongwei Hu, Linsen Ye, Yang Yang. Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04379-2
|
| 15 |
Wulan Li, Qian Liu, Wenyan Xiong, Xu Zhong, Lei Tian. Decoding STAT3: a new frontier in understanding and treating hyperoxic lung injury. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1657823
|
| 16 |
Hua Su, Zhongan Wang, Lidan Zhou, Dezhi Liu, Nian Zhang. Regulation of the Nrf2/HO-1 axis by mesenchymal stem cells-derived extracellular vesicles: implications for disease treatment. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1397954
|